[{"Assets_0_Q3_USD":"640530000.0","CIK":"1743881","CommonStockSharesConverted_0_Q3_shares":"117359502.0","CommonStockSharesOutstanding_0_Q3_shares":"117359502.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.51","EarningsPerShareBasic_3_Q3_USD":"-1.86","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_Q3_USD":"61939000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-177384000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-59980000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-187129000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_1_Q3_USD":"-60664000.0","ProfitLoss_3_Q3_USD":"-204434000.0","RevenuesConverted_1_Q3_USD":"26741000.0","RevenuesConverted_3_Q3_USD":"26741000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"521697000.0","StockholdersEquity_0_Q3_USD":"459758000.0","Ticker":"BBIO","filed":"20191108","footnote":null,"form":"10-Q","fp":"Q3","fy":"2019.0","name":"BRIDGEBIO PHARMA, INC.","period":"20190930","qtrs":"0","uom":"USD"}]